Sicart Associates’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-1,400
| Closed | -$397K | – | 121 |
|
|
2020
Q3 | $397K | Hold |
1,400
| – | – | 0.12% | 74 |
|
|
2020
Q2 | $375K | Hold |
1,400
| – | – | 0.12% | 76 |
|
|
2020
Q1 | $443K | Hold |
1,400
| – | – | 0.17% | 64 |
|
|
2019
Q4 | $415K | Hold |
1,400
| – | – | 0.14% | 76 |
|
|
2019
Q3 | $326K | Hold |
1,400
| – | – | 0.11% | 81 |
|
|
2019
Q2 | $327K | Hold |
1,400
| – | – | 0.13% | 70 |
|
|
2019
Q1 | $331K | Hold |
1,400
| – | – | 0.14% | 68 |
|
|
2018
Q4 | $421K | Hold |
1,400
| – | – | 0.2% | 60 |
|
|
2018
Q3 | $495K | Hold |
1,400
| – | – | 0.24% | 61 |
|
|
2018
Q2 | $406K | Hold |
1,400
| – | – | 0.21% | 67 |
|
|
2018
Q1 | $383K | Hold |
1,400
| – | – | 0.23% | 73 |
|
|
2017
Q4 | $446K | Buy |
+1,400
| New | +$446K | 0.24% | 76 |
|
|
2017
Q1 | – | Sell |
-6,800
| Closed | -$1.93M | – | 91 |
|
|
2016
Q4 | $1.93M | Buy |
+6,800
| New | +$1.93M | 1.33% | 25 |
|